SE466308B - Kinolinderivat - Google Patents

Kinolinderivat

Info

Publication number
SE466308B
SE466308B SE8602524A SE8602524A SE466308B SE 466308 B SE466308 B SE 466308B SE 8602524 A SE8602524 A SE 8602524A SE 8602524 A SE8602524 A SE 8602524A SE 466308 B SE466308 B SE 466308B
Authority
SE
Sweden
Prior art keywords
general formula
acid addition
lower alkyl
compound
radiation
Prior art date
Application number
SE8602524A
Other languages
English (en)
Swedish (sv)
Other versions
SE8602524L (sv
SE8602524D0 (sv
Inventor
E Berenyi
L Varga
L Pallos
L Petocz
L Ladanyi
P Toempe
E Hartai
A Kovacs
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of SE8602524D0 publication Critical patent/SE8602524D0/xx
Publication of SE8602524L publication Critical patent/SE8602524L/xx
Publication of SE466308B publication Critical patent/SE466308B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
SE8602524A 1985-06-04 1986-06-04 Kinolinderivat SE466308B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU852193A HU195487B (en) 1985-06-04 1985-06-04 Process for producing quinoline derivatives

Publications (3)

Publication Number Publication Date
SE8602524D0 SE8602524D0 (sv) 1986-06-04
SE8602524L SE8602524L (sv) 1986-12-05
SE466308B true SE466308B (sv) 1992-01-27

Family

ID=10958222

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8602524A SE466308B (sv) 1985-06-04 1986-06-04 Kinolinderivat

Country Status (28)

Country Link
US (1) US4652562A (it)
JP (1) JPS6248668A (it)
KR (1) KR930006775B1 (it)
CN (1) CN1012957B (it)
AT (1) AT392469B (it)
AU (1) AU588883B2 (it)
BE (1) BE904864A (it)
CA (1) CA1266650A (it)
CH (1) CH668069A5 (it)
CS (1) CS257793B2 (it)
DD (1) DD247448A5 (it)
DE (1) DE3618724C2 (it)
DK (1) DK162841C (it)
ES (1) ES8707231A1 (it)
FI (1) FI82451C (it)
FR (1) FR2582835B1 (it)
GB (1) GB2176185B (it)
GR (1) GR861452B (it)
HU (1) HU195487B (it)
IL (1) IL79024A0 (it)
IT (1) IT1204377B (it)
NL (1) NL8601434A (it)
NO (1) NO165635C (it)
PH (1) PH24135A (it)
PL (1) PL146498B1 (it)
PT (1) PT82712B (it)
SE (1) SE466308B (it)
SU (1) SU1398773A3 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US8974363B2 (en) * 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US20090117199A1 (en) * 1998-08-06 2009-05-07 Scott Timothy C Method of treatment of cancer
US8557298B2 (en) * 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US20020001567A1 (en) * 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US8470296B2 (en) * 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
EP1320529B1 (en) * 2000-09-21 2006-05-24 Smithkline Beecham Plc Quinoline derivatives as antibacterials

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU165520B (it) * 1972-05-05 1974-09-28
IE47458B1 (en) * 1977-11-07 1984-03-21 Leo Pharm Prod Ltd Quinolylguanidine derivatives

Also Published As

Publication number Publication date
DK262186A (da) 1986-12-05
GB2176185B (en) 1988-09-28
IT1204377B (it) 1989-03-01
ES8707231A1 (es) 1987-07-16
SU1398773A3 (ru) 1988-05-23
SE8602524L (sv) 1986-12-05
FR2582835B1 (fr) 1989-01-06
JPH0515705B2 (it) 1993-03-02
CH668069A5 (de) 1988-11-30
KR870000324A (ko) 1987-02-17
NL8601434A (nl) 1987-01-02
DK162841B (da) 1991-12-16
DE3618724A1 (de) 1987-01-08
NO862230L (no) 1986-12-05
FI82451B (fi) 1990-11-30
GB2176185A (en) 1986-12-17
IT8620667A0 (it) 1986-06-04
KR930006775B1 (ko) 1993-07-23
PT82712A (en) 1986-07-01
GR861452B (en) 1986-10-03
PH24135A (en) 1990-03-05
FI82451C (fi) 1991-03-11
FI862381A (fi) 1986-12-05
CS257793B2 (en) 1988-06-15
JPS6248668A (ja) 1987-03-03
FR2582835A1 (fr) 1986-12-05
DE3618724C2 (de) 1994-06-16
FI862381A0 (fi) 1986-06-04
DD247448A5 (de) 1987-07-08
PT82712B (pt) 1988-04-21
BE904864A (fr) 1986-12-03
IL79024A0 (en) 1986-09-30
GB8613530D0 (en) 1986-07-09
US4652562A (en) 1987-03-24
DK262186D0 (da) 1986-06-04
SE8602524D0 (sv) 1986-06-04
CN1012957B (zh) 1991-06-26
AU5834486A (en) 1986-12-11
CA1266650A (en) 1990-03-13
NO862230D0 (no) 1986-06-04
HU195487B (en) 1988-05-30
HUT41008A (en) 1987-03-30
AU588883B2 (en) 1989-09-28
ES555708A0 (es) 1987-07-16
NO165635C (no) 1991-03-13
CN86103688A (zh) 1987-02-11
AT392469B (de) 1991-04-10
ATA149286A (de) 1990-09-15
NO165635B (no) 1990-12-03
PL146498B1 (en) 1989-02-28
DK162841C (da) 1992-05-04

Similar Documents

Publication Publication Date Title
EP1753723B1 (en) Substituted quinoline derivatives as mitotic kinesin inhibitors
US4296114A (en) 3,4-Dihydro-3-oxopyrido[2,3-b]-pyrazines, compositions and use thereof
US6251900B1 (en) Heterocyclic compounds and antitumor agent containing the same as active ingredient
US20070244110A1 (en) Treatment of prostate cancer, melanoma or hepatic cancer
Brana et al. Chromophore-modified bis-naphthalimides: synthesis and antitumor activity of bis-dibenz [de, h] isoquinoline-1, 3-diones
US4656192A (en) Tropolone derivatives, processes for the preparation thereof and the use thereof as anti-tumor agents
SE466308B (sv) Kinolinderivat
PL128791B1 (en) Process for manufacturing novel substituted bis-hydrazones-9,10-anthracene
US3839347A (en) 1-aminobenzimidazoles
Zalaru et al. Synthesis and biological screening of some novel 2-(1H-pyrazol-1-yl)-acetamides as lidocaine analogue
Shablykin et al. Synthesis and anticancer activity of new substituted imidazolidinone sulfonamides
US20100063118A1 (en) Hydantoins Having RNase Modulatory Activity
Kajfez et al. 1-Substitution in 2-methyl-4 (5)-nitroimidazole. I. Synthesis of compounds with potential antitrichomonal activity
US4866066A (en) Thiomethylpyridine derivatives and their use for eliciting a bronchosecretolytic or mucolytic response
US4510307A (en) 6-Quinazolinesulfonyl derivatives and process for preparation thereof
JPS61115069A (ja) 複素環化合物
US5332737A (en) Amino-1,3,5-triazines and their anhydrobase derivatives as agents for cardiovascular system
Anisimova et al. Synthesis and pharmacological activity of 10-alkylaminoethyl-2, 3, 4, 10-tetrahydropyrimido [1, 2-a] benzimidazoles
US11000485B2 (en) Substituted hydroxystilbenes as AhR and Nrf2 modulators and their therapeutic applications
CN102603553A (zh) 具有协同抗真菌作用的化合物及其在药学中的用途
US4218461A (en) 2,3-Dihydro-2-[(1H-imidazol-1-yl)-methylene]-1H-inden-1-ones
Zoltewicz et al. N-methylated 2, 3'-bipyridinium ion. First synthesis of the more sterically hindered isomer
US20240226096A1 (en) Treatment of myeloproliferative diseases and disorders with inhibitors of bet family bdii bromodomain
US4317831A (en) Antimicrobial derivatives of 3-(1H-imidazol-1-yl)-2-propen-1-ones
FI63023B (fi) Foerfarande foer framstaellning av smaertlindrande 4-amino-trans-dekahydrokinolinderivat

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8602524-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8602524-4

Format of ref document f/p: F